D
ClearPoint Neuro, Inc. CLPT
$9.42 -$0.09-0.95% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -25.54M -23.14M -22.22M -20.79M -18.91M
Total Depreciation and Amortization 2.14M 1.86M 1.93M 1.76M 1.90M
Total Amortization of Deferred Charges 182.00K 60.00K 43.00K 36.00K 51.00K
Total Other Non-Cash Items 9.11M 8.82M 8.38M 7.38M 6.61M
Change in Net Operating Assets -9.81M -685.00K 704.00K 335.00K 1.40M
Cash from Operations -23.93M -13.09M -11.17M -11.28M -8.95M
Capital Expenditure -522.00K -736.00K -549.00K -458.00K -275.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 1.14M -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 615.00K -736.00K -549.00K -458.00K -275.00K
Total Debt Issued 48.09M 28.65M 28.65M -- --
Total Debt Repaid -- 0.00 -10.00M -10.00M -10.00M
Issuance of Common Stock 3.95M 3.74M 3.74M 430.00K 16.61M
Repurchase of Common Stock -1.86M -1.75M -1.81M -1.58M -424.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 0.00 0.00 0.00 -78.00K --
Cash from Financing 50.18M 30.65M 20.59M -11.23M 6.19M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 26.87M 16.83M 8.88M -22.97M -3.04M